FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to the development of medicinal preparations and can be used in treatment of bronchial asthma. Invention proposes the inhalation composition comprising salbutamol hemisuccinate or budesonide as active components, and sodium benzoate or succinic acid and/or benzoic acid as a filling agent wherein components are taken in the definite ratio. Invention provides elevating stability of medicinal powder and enhancement of pharmacological activity of active component.
EFFECT: valuable medicinal properties of composition.
3 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
INHALATION COMPOSITION FOR BRONCHIAL ASTHMA TREATMENT | 1992 |
|
RU2054932C1 |
METHOD OF COMBINATION THERAPY OF BRONCHIAL ASTHMA | 2009 |
|
RU2420331C2 |
METHOD FOR TREATING BRONCHIAL ASTHMA COMBINED WITH EROSIVE-ULCEROUS KLESIONS OF GASTRODUODENAL AREA | 2004 |
|
RU2283097C2 |
MEDICINAL AGENT FOR PREVENTION AND ARRESTING BRONCHIAL ASTHMA ATTACK AND MEDICINAL FORMULA | 1996 |
|
RU2097026C1 |
METHOD FOR IMPROVEMENT OF SPUTUM EXPECTORATION | 2016 |
|
RU2609992C1 |
BRONCHOLITHIC PREPARATION AND METHOD FOR ITS OBTAINING | 2000 |
|
RU2203062C2 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
METHOD OF TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2609274C1 |
BRONCHIAL ASTHMA TREATMENT MODE | 2008 |
|
RU2360698C1 |
METHOD FOR TREATING BRONCHIAL ASTHMA | 2005 |
|
RU2309755C2 |
Authors
Dates
2004-12-27—Published
2002-09-06—Filed